Article Details

Accord BioPharma Strengthens Pipeline Through Exclusive U.S. Licensing Agreement with ...

Retrieved on: 2025-02-10 17:23:39

Tags for this article:

Click the tags to see associated articles and topics

Accord BioPharma Strengthens Pipeline Through Exclusive U.S. Licensing Agreement with .... View article details on hiswai:

Summary

The article discusses Accord BioPharma's agreement with Bio-Thera Solutions to commercialize a biosimilar of Simponi (golimumab), highlighting the biopharmaceutical industry's initiatives to expand access to TNF inhibitors like golimumab for treating conditions such as psoriatic arthritis.

Article found on: pipelinereview.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up